C9 Antikörper
(1 reference)Kurzübersicht für C9 Antikörper (ABIN2477820)
Target
Alle C9 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Produktmerkmale
- Purified IgG
-
Aufreinigung
- Purified
-
Immunogen
- Purified human C9
-
Isotyp
- IgG2b
-
-
anti-Complement Component C9 (C9) (AA 191-220), (Center) antibody
C9 Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal RB33918 unconjugated
anti-Complement Component C9 (C9) (AA 22-265) antibodyC9 Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Complement Component C9 (C9) (AA 136-512) antibodyC9 Reaktivität: Maus WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Complement Component C9 (C9) (AA 139-519) antibody (APC)C9 Reaktivität: Kaninchen WB, IHC Wirt: Meerschweinchen Polyclonal APC
anti-Complement Component C9 (C9) (AA 191-220) antibodyC9 Reaktivität: Human WB, IHC, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Complement Component C9 (C9) (AA 336-554) antibodyC9 Reaktivität: Ratte WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Complement Component C9 (C9) (AA 205-216) antibodyVerified C9 Reaktivität: Human WB, ELISA Wirt: Ziege Polyclonal unconjugated
anti-Complement Component C9 (C9) (AA 184-411) antibodyC9 Reaktivität: Human WB, ICC, IHC (p), IF Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1.0 mg/mL
-
-
-
: "Defining the CD59-C9 binding interaction." in: The Journal of biological chemistry, Vol. 281, Issue 37, pp. 27398-404, (2006) (PubMed).
-
: "Defining the CD59-C9 binding interaction." in: The Journal of biological chemistry, Vol. 281, Issue 37, pp. 27398-404, (2006) (PubMed).
-
- C9 (Complement Component C9 (C9))
-
Andere Bezeichnung
- C9
-
Hintergrund
- Synonyms: COMPLEMENT COMPONENT 9
-
Gen-ID
- 735
-
UniProt
- P02748
-
Pathways
- Komplementsystem
Target
-
